Precision Biosciences (DTIL) Operating Income Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 55.96% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 12.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.08% |
| Dec 31, 2025 | 44.75% |
| Sep 30, 2025 | -12.09% |
| Jun 30, 2025 | 9.54% |
| Mar 31, 2025 | 6.82% |
| Dec 31, 2024 | 6.83% |
| Sep 30, 2024 | -22.61% |
| Jun 30, 2024 | 3.73% |
| Mar 31, 2024 | 39.32% |
| Dec 31, 2023 | 14.09% |
| Sep 30, 2023 | 21.99% |
| Jun 30, 2023 | 54.31% |
| Mar 31, 2023 | 21.40% |
| Dec 31, 2022 | 17.87% |
| Sep 30, 2022 | 12.59% |
| Jun 30, 2022 | -7.38% |
| Mar 31, 2022 | -11.93% |
| Dec 31, 2021 | -24.02% |
| Sep 30, 2021 | -3.38% |
| Jun 30, 2021 | 55.83% |
| Mar 31, 2021 | -26.61% |